408 related items for PubMed ID: 15977023
1. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.
Moudgil A, Bagga A, Jordan SC.
Pediatr Nephrol; 2005 Oct; 20(10):1376-81. PubMed ID: 15977023
[Abstract] [Full Text] [Related]
2. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
Przegl Lek; 2006 Oct; 63 Suppl 3():44-8. PubMed ID: 16898486
[Abstract] [Full Text] [Related]
3. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
4. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
Pediatr Nephrol; 2005 Jul 01; 20(7):914-9. PubMed ID: 15891923
[Abstract] [Full Text] [Related]
5. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J, Ehrich JH, Querfeld U.
Nephrol Dial Transplant; 2012 May 01; 27(5):1970-8. PubMed ID: 21976740
[Abstract] [Full Text] [Related]
6. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
Pediatr Int; 2015 May 01; 57(1):85-91. PubMed ID: 25225083
[Abstract] [Full Text] [Related]
7. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A, Hari P, Moudgil A, Jordan SC.
Am J Kidney Dis; 2003 Dec 01; 42(6):1114-20. PubMed ID: 14655181
[Abstract] [Full Text] [Related]
8. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome.
Gargah TT, Lakhoua MR.
J Nephrol; 2011 Dec 01; 24(2):203-7. PubMed ID: 21319130
[Abstract] [Full Text] [Related]
9. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
Querfeld U, Weber LT.
Pediatr Nephrol; 2018 Dec 01; 33(12):2253-2265. PubMed ID: 29750317
[Abstract] [Full Text] [Related]
10. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
Sharma S, Kalra S, Shukla S, Sharma P.
Nephrology (Carlton); 2022 Sep 01; 27(9):758-762. PubMed ID: 35619554
[Abstract] [Full Text] [Related]
11. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
Nephrology (Carlton); 2016 Jan 01; 21(1):21-7. PubMed ID: 26697959
[Abstract] [Full Text] [Related]
12. Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.
Drube J, Geerlings C, Taylor R, Mengel M, Ehrich JH.
Pediatr Nephrol; 2007 Apr 01; 22(4):600-2. PubMed ID: 17235550
[Abstract] [Full Text] [Related]
13. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P.
Pediatr Nephrol; 2005 Apr 01; 20(4):482-5. PubMed ID: 15719253
[Abstract] [Full Text] [Related]
14. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
Clin Nephrol; 2009 Oct 01; 72(4):268-73. PubMed ID: 19825332
[Abstract] [Full Text] [Related]
15. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB.
Pediatr Nephrol; 2003 Aug 01; 18(8):833-7. PubMed ID: 12774223
[Abstract] [Full Text] [Related]
16. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M.
Pediatr Nephrol; 2019 Nov 01; 34(11):2417-2421. PubMed ID: 31435725
[Abstract] [Full Text] [Related]
17. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K.
Eur J Pediatr; 2013 Apr 01; 172(4):513-8. PubMed ID: 23271494
[Abstract] [Full Text] [Related]
18. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
Moorani KN, Hotchandani HM, Zubair AM, Lohana NC, Veerwani NR.
BMC Nephrol; 2019 Jul 03; 20(1):239. PubMed ID: 31269922
[Abstract] [Full Text] [Related]
19. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
Nephrology (Carlton); 2015 Jan 03; 20(1):18-24. PubMed ID: 25312783
[Abstract] [Full Text] [Related]
20. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
Aizawa-Yashiro T, Tsuruga K, Watanabe S, Oki E, Ito E, Tanaka H.
Pediatr Nephrol; 2011 Aug 03; 26(8):1255-61. PubMed ID: 21479767
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
